nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acquired resistance to selective estrogen receptor modulators (SERMs) in clinical practice (tamoxifen & raloxifene) by selection pressure in breast cancer cell populations
|
Fan, Ping |
|
2014 |
90 |
C |
p. 44-52 9 p. |
artikel |
2 |
Development of conjugated estrogens/bazedoxifene, the first tissue selective estrogen complex (TSEC) for management of menopausal hot flashes and postmenopausal bone loss
|
Komm, Barry S. |
|
2014 |
90 |
C |
p. 71-81 11 p. |
artikel |
3 |
Editorial Board
|
|
|
2014 |
90 |
C |
p. ii- 1 p. |
artikel |
4 |
Estrogen receptors alpha (ERα) and beta (ERβ): Subtype-selective ligands and clinical potential
|
Paterni, Ilaria |
|
2014 |
90 |
C |
p. 13-29 17 p. |
artikel |
5 |
From empirical to mechanism-based discovery of clinically useful Selective Estrogen Receptor Modulators (SERMs)
|
Wardell, Suzanne E. |
|
2014 |
90 |
C |
p. 30-38 9 p. |
artikel |
6 |
Introduction to a special edition in Steroids of nuclear hormone receptor modulators
|
Craig Jordan, V. |
|
2014 |
90 |
C |
p. 1-2 2 p. |
artikel |
7 |
Menopausal hormone therapy and cancer: Changing clinical observations of target site specificity
|
Chlebowski, Rowan T. |
|
2014 |
90 |
C |
p. 53-59 7 p. |
artikel |
8 |
Nuclear receptor modulation – Role of coregulators in selective estrogen receptor modulator (SERM) actions
|
Feng, Qin |
|
2014 |
90 |
C |
p. 39-43 5 p. |
artikel |
9 |
Ospemifene: A first-in-class, non-hormonal selective estrogen receptor modulator approved for the treatment of dyspareunia associated with vulvar and vaginal atrophy
|
DeGregorio, Michael W. |
|
2014 |
90 |
C |
p. 82-93 12 p. |
artikel |
10 |
Selective androgen receptor modulators as improved androgen therapy for advanced breast cancer
|
Coss, Christopher C. |
|
2014 |
90 |
C |
p. 94-100 7 p. |
artikel |
11 |
Selective estrogen-induced apoptosis in breast cancer
|
Obiorah, Ifeyinwa E. |
|
2014 |
90 |
C |
p. 60-70 11 p. |
artikel |
12 |
The evolution of nonsteroidal antiestrogens to become selective estrogen receptor modulators
|
Craig Jordan, V. |
|
2014 |
90 |
C |
p. 3-12 10 p. |
artikel |